This is the first study in humans testing an experimental oral medication called BB3008 for advanced solid tumors. The main goal is to find a safe dose and understand how the body processes the drug in 42 patients whose cancers have progressed despite standard treatments. Researc…
Phase: PHASE1 • Sponsor: Broadenbio Ltd., Co. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC